Kev piav qhia
Cov mis mos molecular ntawm qhov nruab nrab no yog C7H7NOS, thiab nws qhov hnyav molecular yog 153.2.Nws cov qauv tshuaj ua lub luag haujlwm tseem ceeb hauv kev tsim cov febuxostat vim nws yog ib qho tseem ceeb hauv cov txheej txheem synthesis.Qhov nruab nrab no yog ib qho tseem ceeb ua ntej rau kev tsim cov febuxostat, uas paub txog nws lub peev xwm los txo cov qib uric acid hauv lub cev, yog li txo cov tsos mob ntawm gout.
Parahydroxythiobenzamide yog cov khoom siv ntau yam siv dav hauv kev lag luam tshuaj rau nws lub luag haujlwm hauv kev tsim cov tshuaj ntau yam.Nws tus lej CAS yog 25984-63-8, ua rau nws yooj yim los txheeb xyuas thiab taug qab rau kev tshawb fawb thiab tsim khoom.Qhov nruab nrab no yog ua tib zoo tsim kom tau raws li cov qauv kev ua tau zoo, ua kom nws cov purity thiab kev ntseeg siab hauv kev siv tshuaj.
Xaiv Peb
JDK muaj cov chaw tsim khoom thawj zaug thiab cov cuab yeej tswj kev ua haujlwm zoo, uas ua kom muaj kev ruaj khov ntawm API intermediates.Pab neeg tshaj lij paub tseeb R & D ntawm cov khoom.Tawm tsam ob qho tib si, peb tab tom nrhiav rau CMO & CDMO hauv kev lag luam hauv tsev thiab thoob ntiaj teb.
